February 2025

Contents

Early access

• Semaglutide reduces alcohol and cigarette use in a randomised phase 2 study

• IAS public letter: Why HIV could be poised for a monumental comeback

• Lenacapavir for PrEP submitted to EMA for EU and global use

• New mpox vaccination sites open in the UK

• Africa CDC special briefing on mpox and the impact of conflict

• Impact of US elections and executive orders on global health: waiver covers PEPFAR with restrictions

Future meetings

• Future meetings and webinars 2025